<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Diagnostic accuracy of melanoma specific structures&lt;sup&gt;[1-4]&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Diagnostic accuracy of melanoma specific structures<sup>[1-4]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Diagnostic accuracy of melanoma specific structures<sup>[1-4]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup width="40%"></colgroup><colgroup span="6" width="10%"></colgroup> <tbody> <tr> <td class="subtitle1" rowspan="2">Melanoma specific structure</td> <td class="subtitle1" colspan="2">Sensitivity (percent)</td> <td class="subtitle1" rowspan="2">Specificity (percent)</td> <td class="subtitle1" rowspan="2">Positive predictive value (percent)</td> <td class="subtitle1" rowspan="2">Negative predictive value (percent)</td> <td class="subtitle1" rowspan="2">Odds ratio*</td> </tr> <tr> <td class="subtitle2">Amelanotic melanoma</td> <td class="subtitle2">Pigmented melanoma</td> </tr> <tr> <td><strong>1. Atypical network</strong><sup>[1,3,5-14]</sup></td> <td class="centered">21</td> <td class="centered">35-82</td> <td class="centered">62-89</td> <td class="centered">18-67</td> <td class="centered">71-88</td> <td class="centered">1.1-9</td> </tr> <tr> <td><strong>2. Peripheral streaks</strong> (pseudopods and radial streaming)<sup>[1,3,5-10,13-15]</sup></td> <td class="centered">5</td> <td class="centered">9-32</td> <td class="centered">77-99</td> <td class="centered">22-77</td> <td class="centered">54-86</td> <td class="centered">1.6-5.8</td> </tr> <tr> <td><strong>3. Negative pigment network</strong> (asymmetrically located and disordered)<sup>[5,16]</sup></td> <td class="centered"> </td> <td class="centered">22</td> <td class="centered">95</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered">1.8</td> </tr> <tr> <td><strong>4. Blotch (off-centered)</strong><sup>[13,14]</sup></td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered">4.1-4.9</td> </tr> <tr> <td><strong>5. Atypical dots and/or globules</strong><sup>[3,6,7,13,14]</sup></td> <td class="centered">24</td> <td class="centered">25-40</td> <td class="centered">74-92</td> <td class="centered">13-79</td> <td class="centered">61-86</td> <td class="centered">2.9-4.8</td> </tr> <tr> <td colspan="7"><strong>6. Regression structures</strong></td> </tr> <tr> <td class="indent1">Scar-like areas<sup>[1,3,5,8]</sup></td> <td class="centered">23</td> <td class="centered">17-36</td> <td class="centered">93-99</td> <td class="centered">89</td> <td class="centered">70</td> <td class="centered">4.4-18.3</td> </tr> <tr> <td class="indent1">Peppering<sup>[3,17]</sup></td> <td class="centered">22</td> <td class="centered">85</td> <td class="centered">93-99</td> <td class="centered">27</td> <td class="centered">99</td> <td class="centered">3.5</td> </tr> <tr> <td class="indent1">Scar-like areas and peppering<sup>[3,5,6,13,14]</sup></td> <td class="centered"> </td> <td class="centered">22-42</td> <td class="centered">93-99</td> <td class="centered">78</td> <td class="centered"> </td> <td class="centered">3.9-7.8</td> </tr> <tr> <td class="indent1">Blue-white veil overlying macular areas and scar-like areas and peppering<sup>[11,12,18]</sup></td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered">44<sup>¶</sup></td> <td class="centered">91<sup>Δ</sup></td> <td class="centered">3.1-8.7</td> </tr> <tr> <td><strong>7. Blue-white veil overlying raised areas</strong><sup>[1,3,5,6,8,9,13,14]</sup></td> <td class="centered">11</td> <td class="centered">17-75</td> <td class="centered">86-99</td> <td class="centered">52-73</td> <td class="centered">55-70</td> <td class="centered">2.5-13</td> </tr> <tr> <td><strong>8. Atypical vascular structures</strong><sup>[3,6,10,13,14,19-21]</sup></td> <td class="centered">63</td> <td class="centered">9.4</td> <td class="centered">54-96</td> <td class="centered">69</td> <td class="centered">53</td> <td class="centered">1.5-7.4</td> </tr> <tr> <td class="indent1">Dotted + serpentine<sup>[3]</sup></td> <td class="centered">30</td> <td class="centered"> </td> <td class="centered">85</td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered">2.3</td> </tr> <tr> <td class="indent1">Serpentine vessels<sup>[3,22]</sup></td> <td class="centered">34</td> <td class="centered"> </td> <td class="centered">80</td> <td class="centered">68</td> <td class="centered"> </td> <td class="centered">2.1</td> </tr> <tr> <td class="indent1">Polymorphous vessels<sup>[3,22]</sup></td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered">68</td> <td class="centered"> </td> <td class="centered">2.1</td> </tr> <tr> <td class="indent1">Milky-red areas<sup>[3,22]</sup></td> <td class="centered">51</td> <td class="centered"> </td> <td class="centered">71</td> <td class="centered" rowspan="2"><br/> <p>77.8</p> </td> <td class="centered"> </td> <td class="centered">2.5</td> </tr> <tr> <td class="indent1">Red globules<sup>[3,22]</sup></td> <td class="centered">21</td> <td class="centered"> </td> <td class="centered">88</td> <td class="centered"> </td> <td class="centered">2.0</td> </tr> <tr> <td><strong>9. Crystalline structures</strong> (also known as Chrysalis and shiny white streaks)<sup>[23]</sup></td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered"> </td> <td class="centered">9.7</td> </tr> <tr> <td><strong>10. Brown peripheral structureless areas</strong><sup>[3,6]</sup></td> <td class="centered">19</td> <td class="centered">63</td> <td class="centered">93-96</td> <td class="centered">94</td> <td class="centered">73</td> <td class="centered">2.9-28</td> </tr> </tbody></table></div><div class="graphic_footnotes">* The odds ratios for the diagnosis of melanoma shown in the table are statistically significant since the 95% confidence intervals do not include the unit.<br/>¶ When involving &gt;50 percent of the lesion.<br/>Δ When involving &lt;50 percent of the lesion.</div><div class="graphic_reference">References: 

<ol>
<li>Soyer HP, Smolle J, Leitinger G, et al. Diagnostic reliability of dermoscopic criteria for detecting malignant melanoma. Dermatol 1995; 190:25.</li>
<li>Marghoob AA, Korzenko AJ, Changchien L, et al. The beauty and the beast sign in dermoscopy. Dermatol Surg 2007; 33:1388.</li>
<li>Menzies SW, Kreusch J, Byth K, et al. Dermoscopic evaluation of amelanotic and hypomelanotic melanoma . Arch Dermatol 2008; 144:1120.</li>
<li>Stoecker WV, Stolz W. Dermoscopy and the diagnostic challenge of amelanotic and hypomelanotic melanoma. Arch Dermatol 2008; 144:1207.</li>
<li>Menzies SW, Ingvar C, McCarthy WH. A sensitivity and specificity analysis of the surface microscopy features of invasive melanoma. Melanoma Res 1996; 6:55.</li>
<li>Annessi G, Bono R, Sampogna F, et al. Sensitivity, specificity, and diagnostic accuracy of three dermoscopic algorithmic methods in the diagnosis of doubtful melanocytic lesions: the importance of light brown structureless areas in differentiating atypical melanocytic nevi from thin melanomas. J Am Acad Dermatol 2007; 56:759.</li>
<li>Haenssle HA, Korpas B, Hansen-Hagge C, et al. Seven-point checklist for dermatoscopy: performance during 10 years of prospective surveillance of patients at increased melanoma risk. J Am Acad Dermatol 2010; 62:785.</li>
<li>Salopek TG, Kopf AW, Stefanato CM, et al. Differentiation of atypical moles (dysplastic nevi) from early melanomas by dermoscopy. Dermatol Clin 2001; 19:337.</li>
<li>Kenet RO, Kang S, Kenet BJ, et al. Clinical diagnosis of pigmented lesions using digital epiluminescence microscopy. Grading protocol and atlas. Arch Dermatol 1993; 129:157.</li>
<li>Pizzichetta MA, Stanganelli I, Bono R, et al. Dermoscopic features of difficult melanoma. Dermatol Surg 2007; 33:91.</li>
<li>Soyer HP, Argenziano G, Zalaudek I, et al. Three-point checklist of dermoscopy. A new screening method for early detection of melanoma.Dermatology 2004; 208:27.</li>
<li>Zalaudek I, Argenziano G, Soyer HP, et al. Three-point checklist of dermoscopy: an open internet study. Br J Dermatol 2006; 154:431.</li>
<li>Argenziano G, Fabbrocini G, Carli P, et al. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol 1998; 134:1563.</li>
<li>Argenziano G, Chimenti S, Talamini R, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol 2003; 48:679.</li>
<li>Dal Pozzo V, Benelli C, Roscetti E. The seven features for melanoma: a new dermoscopic algorithm for the diagnosis of malignant melanoma. Eur J Dermatol 1999; 9:303.</li>
<li>Marghoob AA. Unpublished data.</li>
<li>Braun RP, Gaide O, Oliviero M, et al. The significance of multiple blue-grey dots (granularity) for the dermoscopic diagnosis of melanoma. Br J Dermatol 2007; 157:907.</li>
<li>Zalaudek I, Argenziano G, Ferrara G, et al. Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study. Br J Dermatol 2004; 150:64.</li>
<li>Bono A, Maurichi A, Moglia D, et al. Clinical and dermatoscopic diagnosis of early amelanotic melanoma. Melanoma Res 2011; 11:491.</li>
<li>Pizzichetta MA, Talamini R, Stanganelli I, et al. Amelanotic/hypomelanotic melanoma: Clinical and dermoscopic features. Br J Dermatol 2004; 150:1117.</li>
<li>Puig S, Argenziano G, Zalaudek I, et al. Melanomas that failed dermoscopic detection: A combined clinicodermoscopic approach for not missing melanoma. Dermatol Surg 2007; 33:1262.</li>
<li>Argenziano G, Zalaudek I, Corona R, et al. Vascular structures in skin tumors: a dermoscopy study. Arch Dermatol 2004; 140:1485.</li>
<li>Balagula Y, Braun RP, Rabinovitz HS, et al. The significance of crystalline/chrysalis structures in the diagnosis of melanocytic and nonmelanocytic lesions. J Am Acad Dermatol 2011. Epub ahead of print.</li></ol>Reproduced with permission from Drs. Ashfaq Marghoob and Natalia Jaimes.</div><div id="graphicVersion">Graphic 74394 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
